A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE

Intensive Course in Cancer Risk Assessment

Intensive Course in Cancer Risk Assessment

 
Reaching Clinicians Around the Globe
 
City of Hope's Intensive Course in Cancer Risk Assessment has trained health professionals in community settings across the United States as well as in Argentina, Brazil, Canada, Chile, Columbia, Germany, Hong Kong, Mexico, Peru, Philippines, Puerto Rico, Spain, and Uruguay.
 

Accreditation

CME Credits
Accreditation Statement: Accreditation in process

Credit Designation: City of Hope designates this educational activity for a maximum of (TBD) AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

The following may apply CME Category 1 credit for license renewal:

Registered Nurses: Nurses may report up to (TBD) credit hours toward the continuing education requirements for license renewal by their state Board of Registered Nurses (BRN). CME may be noted on the license renewal application in lieu of a BRN provider number.

Physician’s Assistants: The National Commission on Certification of Physician Assistants states that AMA accredited Category 1 courses are acceptable for CME requirements for recertification.

Genetic Counselor CEUs: The American Board of Genetic Counseling (ABGC) accepts CEUs approved by the National Society for Genetic Counselors (NSGC) for purposes of recertification. This event has been submitted to NSGC for approval of Category 1 CEUs and is approved for (TBD) CEUs and (TBD) Contact Hours.

Disclosure
The City of Hope adheres to ACCME Essential Areas, Standards for Commercial Support, and Policies regarding industry support of continuing medical education. Disclosure of the commercial relationships of everyone in a position to control content of an educational activity will be made at the activity. Speakers are also required to openly disclose discussion of any off-label, experimental, or investigational use of drugs or devices in their presentations.
 
No partial credit will be given. Participants should claim only those hours of credit that they actually spent at the educational activity.
 

Application Process

Application Deadline
Enrollment for the 2014 Winter course will begin on June 20, 2013. The deadline will be August 16, 2013.
 
Requirements
 
Please read all terms stated below before submitting application.

To receive full course credit, and certificate of course completion, course participants will be required to:
 
  • Participate in all distance and on-campus course related activities.
  • Complete all distance learning lecture modules delivered via Website and USB drive (flashdrive) interface by given deadlines.
  • Complete all pre- and post-course surveys, knowledge questionnaires, evaluations, and assignments as directed.
  • Agree to complete prescribed post-course professional development activities as outlined in the course syllabus. Some activities are required to be completed at 6-months post training and some must be completed by 1-year post training.
 
How to Apply
 
Complete the Intensive Course Application. Submit the completed application form, letter of support and curriculum vitae by regular mail, e-mail or fax to:
 
Gloria Nuñez, Conference Coordinator
City of Hope
Division of Clinical Cancer Genetics, Mod 173
1500 East Duarte Road
Duarte, CA 91010-3000

Fax:
626-930-5495

E-mail:
gnunez@coh.org (note subject as "Intensive Course")
 
Selection Criteria

Ideal candidates are healthcare professionals in clinical practice with a minimum of two years of training or experience in either oncology or genetics, or experience in cancer risk counseling, including physicians, genetic counselors and advanced practice oncology or genetics nurses. Twenty five (25) participants per session will be competitively selected by the department directors, faculty and advisory board based upon academic and clinical background, and professional and institutional goal statements defining intent to provide clinical cancer genetics risk assessment services and participate in research collaboration.
 
Acceptance
 
Applicants will be notified of acceptance by September 30, 2013, via e-mail. The non-refundable course fee (TBD) will be due on or before October 31, 2013.
 
Please NOTE: Applications will not be accepted without the items listed below.
 
  • Completed application form
  • Current curriculum vitae (CV)
  • Letter from your institution indicating that protected time will be provided for course participation, and statement that you will have institutional support to provide cancer risk assessment upon return to your community (if applicable).
 

Faculty

Course Co-directors
Jeffrey N. Weitzel , M.D.
Director, Division of Clinical Cancer Genetics
and
Kathleen R. Blazer , EdD, MS, LCGC
Assistant Director, Cancer Genetics Education Program

City of Hope Faculty
Cathy Cole, RNC, NP, MPH
Josef Herzog, BS
Ilana Solomon, ScM, MS, CGC
Hazel Mariveles, BS
Robert Morgan, Jr., MD, FACP
Joyce Niland, PhD
Melanie R. Palomares, MD
Lacolle Robinson, BA
Sharon Sand, BA, CCRP
April Sorrell, MD
Sharon Wilczynski, MD, PhD

Guest Faculty
Debbie Barragan, MS, CGC
Kimberly Banks, MS, CGC, Saint Joseph's Medical Center
Julie Culver, MS, LCGC
Allan Ebbin, MD, MPH
Carin Espenschied, MS, LCGC
Carol Fabian, MD
Harry Gao, MD, PhD, FACMG
Lucille Leong, MD
Katrina Lowstuter, MS, CGC, Myriad Genetic Laboratories Inc.
Deborah J. MacDonald, PhD, RN, APNG
Phuong Mai, MD, National Cancer Institute
Susan Neuhausen, PhD, University of California Irvine
Raquel Ogaz, BA, City of Hope
Gloria Petersen, PhD, Mayo Clinic
Charite Ricker, MS, CGC, USC/ Norris Cancer Hospital
Juan-Sebastian Saldivar, PhD,City of Hope

Administrative Staff
Gloria Nuñez, Conference Coordinator
Stacy Berger, Programmer Analyst
Larry Kiang, Technology Specialist
Tracy Sulkin, Education Assistant

Intensive Course Alumni

 
 
City of Hope's Intensive Course in Cancer Risk Assessment has trained health professionals in community settings across the United States as well as in Argentina, Brazil, Canada, Chile, Columbia, Germany, Hong Kong, Mexico, Peru, Philippines, Puerto Rico, Spain, and Uruguay.
 
 
The embedded asset does not exist:
Asset Type: CoH_Media_C
Asset Id: 1365740472076
PAGENAME: COH/EmbedLink
The embedded asset does not exist:
Asset Type: CoH_Media_C
Asset Id: 1365740471953
PAGENAME: COH/EmbedLink
The embedded asset does not exist:
Asset Type: CoH_Media_C
Asset Id: 1365740472203
PAGENAME: COH/EmbedLink
The embedded asset does not exist:
Asset Type: CoH_Media_C
Asset Id: 1365740472219
PAGENAME: COH/EmbedLink
The embedded asset does not exist:
Asset Type: CoH_Media_C
Asset Id: 1365740472251
PAGENAME: COH/EmbedLink
The embedded asset does not exist:
Asset Type: CoH_Media_C
Asset Id: 1365740472267
PAGENAME: COH/EmbedLink
The embedded asset does not exist:
Asset Type: CoH_Media_C
Asset Id: 1365740472399
PAGENAME: COH/EmbedLink
The embedded asset does not exist:
Asset Type: CoH_Media_C
Asset Id: 1365740472399
PAGENAME: COH/EmbedLink
The embedded asset does not exist:
Asset Type: CoH_Media_C
Asset Id: 1365740472431
PAGENAME: COH/EmbedLink
The embedded asset does not exist:
Asset Type: CoH_Media_C
Asset Id: 1365740472460
PAGENAME: COH/EmbedLink
The embedded asset does not exist:
Asset Type: CoH_Media_C
Asset Id: 1365740472566
PAGENAME: COH/EmbedLink
The embedded asset does not exist:
Asset Type: CoH_Media_C
Asset Id: 1365740472588
PAGENAME: COH/EmbedLink
The embedded asset does not exist:
Asset Type: CoH_Media_C
Asset Id: 1365740472604
PAGENAME: COH/EmbedLink
The embedded asset does not exist:
Asset Type: CoH_Media_C
Asset Id: 1365740472628
PAGENAME: COH/EmbedLink
The embedded asset does not exist:
Asset Type: CoH_Media_C
Asset Id: 1365740472698
PAGENAME: COH/EmbedLink
The embedded asset does not exist:
Asset Type: CoH_Media_C
Asset Id: 1365740472714
PAGENAME: COH/EmbedLink

Intensive Course Information

General Course Description
 
City of Hope's Intensive Course in Cancer Risk Assessment is flexible to accommodate the needs of participants with varied training backgrounds and practice settings. Coursework includes multidisciplinary didactics, interactive case conferencing, molecular genetics wet-lab and training in the use of informatics resources.
 
Objectives
 
At the conclusion of the course the participants should be able to:
  • Integrate cancer genetics and oncology knowledge into clinical practice
  • Apply skills commensurate with practitioner-level proficiency into the cancer risk assessment and case management process
  • Recommend risk-appropriate options for cancer surveillance and prevention as part of the cancer risk assessment, including imaging, chemo preventive and surgical interventions
  • Incorporate understanding of medical, legal, and psychosocial ramifications of cancer risk counseling and testing into clinical practice and research collaboration
  • Discuss clinical research methodologies in cancer genetics epidemiology and cancer prevention trials for high-risk cohorts
  • Recognize the roles and practical issues related to Human Subjects Protections, Informed Consent, Institutional Review Board and HIPAA in clinical research
  • Provide resources and information on current hereditary cancer registries, cancer epidemiology and cancer prevention studies to patients and professional colleagues
  • Use research training and support to participate in collaborative research activities
  • Realize greater professional self-efficacy related to cancer risk counseling and research participation skills
  • Incorporate web-based resources into ongoing practice-based education, professional development and research network support
 
Course Fees
 
The course is supported in part by funding from the NCI (IRC4CA153828-01 and IR25 CA112486). The non-refundable fees* (TBD) cover course materials, breakfasts, lunches, and receptions not supported by grant funding. Lodging and travel costs are not included in the course fee; however, the hotel provides a reduced group-rate of $65 per night for shared housing and $129 per night for single occupancy.

*For more information regarding registration fees, please email the Intensive Course coordinator at gnunez@coh.org.

Schedule

Tentative Course Agenda
Download a copy of the  IC Calendar 2014W for the City of Hope Intensive Course in Cancer Risk Assessment.
 
Web Conference Orientation: Friday, November 22, 2013, from 8-11 a.m. PT
 
Phase 1: 11 Weeks Distance Learning through February 21, 2014*
11 Weeks Distance Didactic Modules with weekly Web-based discussion sessions (Fridays, 8-10 a.m. PT) Working Group Case Conferences (Live or Recorded) (Wednesdays, 9:30-11:30 a.m. PT)
 
Phase 2: February 25 - February 28, 2014 (4 days)
Face-to-face Cancer Genetics Workshops on the City of Hope campus in Duarte, California
 
Phase 3: Post-conference Work (1 year)
12 Months continued professional development, clinical & research collaboration support via WebConference & discussion board activities
 
*Phase 1 course work averages to 3-4 self-directed modules per week (each about 1 hour long), with required weekly 2-hour Friday Web conference and five 2-hour Working Group Case Conference Sessions to complete during the Distance Learning segment of the course. (The Winter Session encompasses two holiday breaks--Thanksgiving and Christmas.)
 
This schedule is subject to change. If you have questions related to the course or application process, phone or e-mail Intensive Course Conference Coordinator, 626-256-8662, cgep@coh.org (note subject as "Intensive Course").
 
Education and Training
As one of only a select few National Cancer Institute-designated Comprehensive Cancer Centers in the country, City of Hope integrates all aspects of cancer research, treatment and education. We offer a range of programs serving students, post-doctoral trainees, health and medical professionals.

City of Hope’s Irell & Manella Graduate School of Biological Sciences equips students with the skills and strategies to transform the future of modern medicine.
City of Hope has a long-standing commitment to Continuing Medical Education (CME), sharing advances in cancer research and treatment with the health-care community through CME courses such as conferences, symposia and other on and off campus CME opportunities for medical professionals.
Local and national conferences, in-depth educational training and a certification program provide both current and aspiring health professionals opportunities to further their knowledge in their fields of interest.
 
 
City of Hope offers a range of programs and services, such as Graduate Medical Education & Clinical Training, that serve students, post-doctoral trainees, medical professionals and staff.
The goal of the Postdoctoral Training Office is to ensure the postdoctoral experience at City of Hope is rewarding and meaningful to all participants.
NEWS & UPDATES
  • For most of her life, Southern California teenager Kayla Saikaly described herself as healthy, even very healthy. She played basketball. She never missed school with as much as a fever. Her worst childhood illness was nothing more than a cold. Then, when she was 13, her nose started bleeding after a basketball ...
  • Neuroblastoma is one of the deadliest childhood cancers, accounting for 15 percent of pediatric cancer deaths. For patients with high-risk neuroblastomas, the five-year survival rate is 40 to 50 percent even with the most rigorous treatments available today. But those odds may improve soon, thanks to a new comp...
  • For breast cancer survivors, a common worry is a recurrence of their cancer. Currently, these patients are screened with regular mammograms, but there’s no way to tell who is more likely to have a recurrence and who is fully cleared of her cancer. A new blood test – reported in Cancer Research, a journal of the...
  • Metastasis — the spreading of cancer cells from a primary tumor site to other parts of the body — generally leads to poorer outcomes for patients, so oncologists and researchers are constantly seeking new ways to detect and thwart this malicious process. Now City of Hope researchers may have identified a substa...
  • Deodorant, plastic bottles, grilled foods, artificial sweeteners, soy products … Do any of these products really cause cancer? With so many cancer myths and urban legends out there, why not ask the experts? They can debunk cancer myths while sharing cancer facts that matter, such as risk factors, preventi...
  • Cancer risk varies by ethnicity, as does the risk of cancer-related death. But the size of those differences can be surprising, highlighting the health disparities that exist among various ethnic groups in the United States. Both cancer incidence and death rates for men are highest among African-Americans, acco...
  • George Winston, known worldwide for his impressionistic, genre-defying music, considers music to be his first language, and admits he often stumbles over words – especially when he attempts languages other than English. There’s one German phrase he’s determined to perfect, however: danke schön. Winston thinks h...
  • Few decisions are more important than those involving health care, and few decisions can have such lasting impact, not only on oneself but on relatives and loved ones. Those choices, especially, should be made in advance – carefully, deliberately, free of pain and stress, and with much weighing of values and pr...
  • Using a card game to make decisions about health care, especially as those decisions relate to the end of life, would seem to be a poor idea. It isn’t. The GoWish Game makes those overwhelming, but all-important decisions not just easy, but natural. On each card of the 36-card deck is listed what seriously ill,...
  • Young adults and adolescents with cancer face unique challenges both during their treatment and afterward. Not only are therapies for children and older adults not always appropriate for them, they also must come to terms with the disease and treatment’s impact on their relationships, finances, school or ...
  • Breast cancer is the most common cancer, other than skin cancer, among women in the United States. It’s also the second-leading cause of cancer death, behind lung cancer. In the past several years, various task force recommendations and studies have questioned the benefits of broad screening guidelines fo...
  • Paternal age and the health effects it has on potential offspring have been the focus of many studies, but few have examined the effect parental age has on the risk of adult-onset hormone-related cancers (breast cancer, ovarian cancer and endometrial cancer). A team of City of Hope researchers, lead by Yani Lu,...
  • Hormone therapy, which is prescribed to women for relief of menopausal symptoms such hot flashes, night sweats and vaginal dryness, has recently seen a decline in popularity (and use) due to its link to an increased risk of breast and endometrial cancer. But City of Hope researchers have found that menopausal h...
  • Myeloproliferative neoplasms can’t be narrowed down to a single cancer, but they can be described by a defining characteristic: too many blood cells. The diseases bring with them a host of frustrating, potentially life-altering symptoms, and management of the diseases and their symptoms is crucial. An upcoming ...
  • More than 18,000 researchers, clinicians, advocates and other professionals will convene at the 105th American Association for Cancer Research (AACR) annual meeting taking place in San Diego from April 5 to 9. With more than 6,000 findings being presented over this five-day period, the amount of information can...